logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Biora Therapeutics, Inc.


USPTO Granted Patents = 17



Forward Citations = 6

Loading Chart...
Loading Chart...

29 inventors (with patents filed for the assignee):

goldMedal Mitchell Lawrence Jones (17 out of 33 patents)

silverMedal Christopher Loren Wahl (16 out of 23 patents)

bronzeMedal Sharat Singh (10 out of 95 patents)

4.  Harry Stylli (7 out of 15 patents)

5.  Mark Sasha Drlik (4 out of 18 patents)

6.  Nathan John Muller (4 out of 10 patents)

7.  Iman Niknia (4 out of 5 patents)

8.  Kevin Howe (4 out of 4 patents)

9.  Jeffrey A Shimizu (3 out of 5 patents)

10.  Tuyen Nguyen (3 out of 5 patents)

11.  Nicholas Mark Salt (3 out of 4 patents)

12.  Edward Mudge (3 out of 4 patents)

13.  Nia Eleri Stevens (3 out of 4 patents)

14.  Stuart Robert Abercrombie (3 out of 4 patents)

15.  Christopher Ian Bunce (3 out of 4 patents)


17 patents:

1. 12227565 - Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine (2025-02-18),
2. 12171764 - Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor (2024-12-24),
3. 12150775 - Treatment of a disease of the gastrointestinal tract with an immunosuppressant (2024-11-26),
4. 12089916 - Gastrointestinal tract detection methods, devices and systems (2024-09-17),
5. 12053271 - Electromechanical pill device with localization capabilities (2024-08-06),
6. 11938295 - Ingestible device for delivery of therapeutic agent to the gastrointestinal tract (2024-03-26),
7. 11918342 - Localization systems and methods for an ingestible device (2024-03-05),
8. 11857669 - Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices (2024-01-02),
9. 11793420 - Ingestible device for delivery of a dispensable substance (2023-10-24),
10. 11707610 - Ingestible device for delivery of therapeutic agent to the gastrointestinal tract (2023-07-25),
11. 11597762 - Treatment of a disease of the gastrointestinal tract with an IL-12/IL-23 inhibitor released using an ingestible device (2023-03-07),
12. 11596670 - Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist (2023-03-07),
13. 11547301 - Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract (2023-01-10),
14. 11523772 - Treatment of a disease of the gastrointestinal tract with an immunosuppressant (2022-12-13),
15. 11471134 - Ingestible device recovery system (2022-10-18),
Biora Therapeutics, Inc. is a biotechnology company focusing on developing innovative therapeutics for rare diseases. With a strong team of scientists and researchers, Biora is dedicated to advancing treatments that improve the lives of patients with unmet medical needs.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#326 in San Diego, CA

#4,375 in California

#18,334 in US

#34,861 in the World

...
San Diego, CA, United States of America

Biora Therapeutics, Inc.

Forward Citations = 6

29 inventors:

goldMedal Mitchell Lawrence Jones (17 out of 33 patents)

silverMedal Christopher Loren Wahl (16 out of 23 patents)

bronzeMedal Sharat Singh (10 out of 95 patents)

4.  Harry Stylli (7 out of 15 patents)

5.  Mark Sasha Drlik (4 out of 18 patents)

Please report any incorrect information to support@idiyas.com
Loading…